Last updated on September 2017

A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer


Brief description of study

A Multinational, Randomised, Double-blind, Placebo-controlled, Phase III Efficacy and Safety Study of BAY1841788 (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate Cancer

Detailed Study Description

The purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.

For Study Locations, Click Here

Clinical Study Identifier: TX153154

Contact Investigators or Research Sites near you

Start Over

Research Center

Research Center
Additional Locations, XX Colombia
  Connect »

Research Center

Research Center
Additional Locations, ID USA
  Connect »

Research Center

Research Center
Additional Locations, IN USA
  Connect »